IP Australia extends period for requesting extensions of time for deadlines which cannot be met due to COVID-19

Initially, in April 2020, IP Australia announced that free extensions of time of up to three months could be requested until 31 May 2020 when a deadline could not be met due to the effects of COVID-19.  We are pleased to report that this period has now been extended until 30 June 2020.  Depending on

Switching from Biologic to Biosimilar: Australia’s Unique Approach

Switching patients from an originator biologic (the reference product) to a biosimilar version has been a topic of keen interest in recent years, both in Australia and globally, as more biosimilars have emerged onto the market. This trend has flowed from the expiration of data exclusivity and patent protection for a number of important originator

The distinction between repair and re-making: The Full Court clarifies the law on refurbishing a patented product

This important decision by the Full Court of the Federal Court in Calidad Pty Ltd v Seiko Epson Corporation [2019] FCAFC 115 clarifies the position on an area of law that, surprisingly, is still developing in Australia, namely the scope of the implied licence issuing from the sale of a patented product.   Re-manufacturers that